Comac Medical is honored to participate in the American Society of Clinical Oncology (ASCO) Annual Meeting 2025, taking place from 30 May–3 June 2025 in Chicago, Illinois. As one of the most prestigious oncology conferences worldwide, ASCO unites clinicians, researchers, and industry leaders to share groundbreaking advances in cancer care. 

This year’s agenda explores of oncology’s most pressing challenges and emerging opportunities. Attendees can look forward to the Plenary Session, showcasing practice-changing research, as well as over 5000 abstracts titles submitted. The meeting also includes Clinical Science Symposia, interactive case-based panels, and insightful joint sessions with AACR and ESMO. With over 2,700 poster presentations, including Trials in Progress, ASCO 2025 promises to be a dynamic platform for collaboration and innovation. 

Representing Comac Medical at ASCO 2025 are Christopher Lancaster and Kelly Conti, two of our newly appointed Senior Business Development Directors, who are eager to connect with oncology professionals from across the globe.

This event offers a valuable opportunity to expand our network and showcase Comac Medical’s commitment to advancing oncology research on a global scale. 

Contact us to arrange a meeting with Chris or Kelly at ASCO 2025, we look forward to exploring opportunities to collaborate and drive progress together.